Norcolut with immune modulators in the complex treatment for hyperplastic uterine processes.
The results are presented of the treatment of 55 patients for hyperplastic endometrial processes with the preparation norcolut combined with the immune modulators thymalinum and myelopidum. It was found that the application of the suggested schemes of the introduction of the medicines mentioned increase the treatment effectiveness and enlarges its possibilities.
Zaporozhan
V N
VN
Family Health Centre, Odessa Medical Institute, Advanced Training Faculty.
Khait
O V
OV
Tumasyan
K P
KP
D028341:Activins; D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D004338:Drug Combinations; D004714:Endometrial Hyperplasia / Q000097:blood / Q000188:drug therapy*; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005500:Follow-Up Studies; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007273:Injections, Intramuscular; D007986:Luteinizing Hormone / Q000097:blood; D008598:Menstruation / Q000187:drug effects; D009640:Norethindrone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009842:Oligopeptides; D010455:Peptides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011374:Progesterone / Q000097:blood; D013951:Thymus Hormones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D004338:Drug Combinations; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D009842:Oligopeptides; D010455:Peptides; D013951:Thymus Hormones; C044147:activin B; D028341:Activins; C048617:myelopeptides; D011374:Progesterone; D004958:Estradiol; C032805:thymalin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D009640:Norethindrone